# Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus

> **NCT04030091** · PHASE4 · COMPLETED · sponsor: **Sciema UG** · enrollment: 24 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2
- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** 3 hours humulin R 100 IU/mL PIT
- **DRUG:** 2 hours humulin R 100 IU/mL PIT

## Key facts

- **NCT ID:** NCT04030091
- **Lead sponsor:** Sciema UG
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-06
- **Primary completion:** 2020-10-19
- **Final completion:** 2020-12-31
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2021-04-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04030091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04030091, "Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04030091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*